These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33040007)

  • 1. 'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
    Logeman C; Cho Y; Sautenet B; Rangan GK; Gutman T; Craig J; Ong A; Chapman A; Ahn C; Coolican H; Tze-Wah Kao J; Gansevoort RT; Perrone R; Harris T; Torres V; Fowler K; Pei Y; Kerr P; Ryan J; Johnson D; Viecelli A; Geneste C; Kim H; Kim Y; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Parasivam G; Tong A
    BMJ Open; 2020 Oct; 10(10):e038005. PubMed ID: 33040007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
    Cho Y; Sautenet B; Gutman T; Rangan G; Craig JC; Ong AC; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort R; Perrone RD; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Johnson DW; Viecelli AK; Geneste C; Kim H; Kim Y; Oh YK; Teixeira-Pinto A; Logeman C; Howell M; Ju A; Manera KE; Tong A
    Nephrology (Carlton); 2019 Dec; 24(12):1214-1224. PubMed ID: 30663163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.
    Tong A; Rangan GK; Ruospo M; Saglimbene V; Strippoli GF; Palmer SC; Tunnicliffe DJ; Craig JC
    Nephrol Dial Transplant; 2015 May; 30(5):790-800. PubMed ID: 25637642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Interview Study of Patient and Caregiver Perspectives on Advance Care Planning in ESRD.
    Sellars M; Clayton JM; Morton RL; Luckett T; Silvester W; Spencer L; Pollock CA; Walker RG; Kerr PG; Tong A
    Am J Kidney Dis; 2018 Feb; 71(2):216-224. PubMed ID: 29132946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
    Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
    Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
    Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
    Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fertility willingness and acceptability of preimplantation genetic testing in Chinese patients with autosomal dominant polycystic kidney disease.
    Sun M; Xue C; Lu Y; Ma Y; Pan T; Wang X; Fan L; Shen J; Hao Y; Zheng D; Li J; Li M; He Y; Mei C
    BMC Nephrol; 2020 Apr; 21(1):147. PubMed ID: 32334565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.
    Harris T; Bridges HR; Brown WD; O'Brien NL; Daly AC; Jindal BK; Mundy GS; Ong A; Power AJ; Sandford RN; Sayer J; Simms RJ; Wilson PD; Winyard PJD; Tarpey M
    BMJ Open; 2022 Jun; 12(6):e055780. PubMed ID: 35705349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants.
    ; Harris T; Sandford R; ;
    Nephrol Dial Transplant; 2018 Apr; 33(4):563-573. PubMed ID: 29309655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative Study.
    Oberdhan D; Palsgrove AC; Cole JC; Harris T
    Kidney Med; 2023 Feb; 5(2):100587. PubMed ID: 36686593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
    Simms RJ; Thong KM; Dworschak GC; Ong AC
    Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental perspectives on the financial impact of caring for a child with CKD.
    Medway M; Tong A; Craig JC; Kim S; Mackie F; McTaggart S; Walker A; Wong G
    Am J Kidney Dis; 2015 Mar; 65(3):384-93. PubMed ID: 25245301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study.
    Walker RC; Howard K; Morton RL; Palmer SC; Marshall MR; Tong A
    Nephrol Dial Transplant; 2016 Jan; 31(1):133-41. PubMed ID: 26346314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease.
    Sujansky E; Kreutzer SB; Johnson AM; Lezotte DC; Schrier RW; Gabow PA
    Am J Med Genet; 1990 Apr; 35(4):510-5. PubMed ID: 2333880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Perspectives on ADPKD.
    Gittus M; Harris T; Ong AC
    Adv Kidney Dis Health; 2023 May; 30(3):294-302. PubMed ID: 37088530
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.